Your browser doesn't support javascript.
loading
Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells.
Tsuchiya, Nobuhiro; Zhang, Rong; Iwama, Tatsuaki; Ueda, Norihiro; Liu, Tianyi; Tatsumi, Minako; Sasaki, Yutaka; Shimoda, Ranmaru; Osako, Yuki; Sawada, Yu; Kubo, Yosuke; Miyashita, Azusa; Fukushima, Satoshi; Cheng, Zhao; Nakaki, Ryo; Takubo, Keiyo; Okada, Seiji; Kaneko, Shin; Ihn, Hironobu; Kaisho, Tsuneyasu; Nishimura, Yasuharu; Senju, Satoru; Endo, Itaru; Nakatsura, Tetsuya; Uemura, Yasushi.
Afiliación
  • Tsuchiya N; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa 277-8577, Japan; Department of Gastroenterological Surgery, Graduate School of Medicine, Yokohama City University, Yokohama 236-0004, Japan.
  • Zhang R; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa 277-8577, Japan; Division of Immunology, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.
  • Iwama T; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa 277-8577, Japan.
  • Ueda N; Division of Immunology, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan; Shin Kaneko Laboratory, Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan.
  • Liu T; Division of Immunology, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan; Key Laboratory of Cancer Center, Chinese PLA General Hospital, Beijing 100853, China.
  • Tatsumi M; Division of Immunology, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.
  • Sasaki Y; Department of Stem Cell Biology and Regenerative Medicine, Graduate School of Medical Science, Kansai Medical University, Hirakata 573-1010, Japan.
  • Shimoda R; Rhelixa, Inc., Tokyo 101-0032, Japan.
  • Osako Y; Rhelixa, Inc., Tokyo 101-0032, Japan.
  • Sawada Y; Department of Gastroenterological Surgery, Graduate School of Medicine, Yokohama City University, Yokohama 236-0004, Japan.
  • Kubo Y; Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
  • Miyashita A; Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
  • Fukushima S; Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
  • Cheng Z; Department of Hematology, Institute of Molecular Hematology, The Second Xiang-ya Hospital, Central South University, Changsha, Hunan 410011, China.
  • Nakaki R; Rhelixa, Inc., Tokyo 101-0032, Japan.
  • Takubo K; Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
  • Okada S; Division of Hematopoiesis, Center for AIDS Research, Kumamoto University, Kumamoto 860-8556, Japan.
  • Kaneko S; Shin Kaneko Laboratory, Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan.
  • Ihn H; Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
  • Kaisho T; Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama 641-8509, Japan.
  • Nishimura Y; Department of Immunogenetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
  • Senju S; Department of Immunogenetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan. Electronic address: senjusat@gpo.kumamoto-u.ac.jp.
  • Endo I; Department of Gastroenterological Surgery, Graduate School of Medicine, Yokohama City University, Yokohama 236-0004, Japan.
  • Nakatsura T; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa 277-8577, Japan.
  • Uemura Y; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa 277-8577, Japan; Division of Immunology, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan. Electronic address: yuemura@east.ncc.go.jp.
Cell Rep ; 29(1): 162-175.e9, 2019 10 01.
Article en En | MEDLINE | ID: mdl-31577946
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Dendríticas / Interferón Tipo I / Receptores de Quimiocina / Células Mieloides / Células Madre Pluripotentes Inducidas / Inmunidad Límite: Animals Idioma: En Revista: Cell Rep Año: 2019 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Dendríticas / Interferón Tipo I / Receptores de Quimiocina / Células Mieloides / Células Madre Pluripotentes Inducidas / Inmunidad Límite: Animals Idioma: En Revista: Cell Rep Año: 2019 Tipo del documento: Article País de afiliación: Japón